BRPI0704182A2 - pharmaceutical composition, process for preparing said composition and use thereof - Google Patents
pharmaceutical composition, process for preparing said composition and use thereofInfo
- Publication number
- BRPI0704182A2 BRPI0704182A2 BRPI0704182A BRPI0704182A2 BR PI0704182 A2 BRPI0704182 A2 BR PI0704182A2 BR PI0704182 A BRPI0704182 A BR PI0704182A BR PI0704182 A2 BRPI0704182 A2 BR PI0704182A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- pharmaceutical composition
- preparing
- prophylaxis
- pharmaceutical
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
COMPOSIçãO FARMACêUTICA, PROCESSO DE PREPARAçãO DA REFERIDA COMPOSIçãO E USO DA MESMA. A presente invenção refere-se a uma composição farmacêutica para profilaxia de anomalias fetais, ocasionadas pelo mau fechamento do tubo neural e ainda para a profilaxia de doenças neurológicas e/ou cognitivas, tais como Alzheimer e demência senil entre outras. A referida composição consiste na associação das substâncias de seu princípio ativo em uma única forma farmacêutica. Adicionalmente, a presente concretização refere-se a um processo de preparação da referida composição farmacêutica e ao uso da mesma.PHARMACEUTICAL COMPOSITION, PREPARATION PROCESS FOR SUCH COMPOSITION AND USE. The present invention relates to a pharmaceutical composition for prophylaxis of fetal anomalies caused by poor neural tube closure and for the prophylaxis of neurological and / or cognitive diseases such as Alzheimer's and senile dementia among others. This composition consists in the association of the substances of its active principle in a single pharmaceutical form. Additionally, the present embodiment relates to a process for preparing said pharmaceutical composition and the use thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0704182 BRPI0704182A2 (en) | 2007-09-25 | 2007-09-25 | pharmaceutical composition, process for preparing said composition and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0704182 BRPI0704182A2 (en) | 2007-09-25 | 2007-09-25 | pharmaceutical composition, process for preparing said composition and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0704182A2 true BRPI0704182A2 (en) | 2009-05-26 |
Family
ID=40671625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0704182 BRPI0704182A2 (en) | 2007-09-25 | 2007-09-25 | pharmaceutical composition, process for preparing said composition and use thereof |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0704182A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016123076A1 (en) * | 2015-01-27 | 2016-08-04 | La Vita Compounding Pharmacy | Stable 5-methyltrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms |
-
2007
- 2007-09-25 BR BRPI0704182 patent/BRPI0704182A2/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016123076A1 (en) * | 2015-01-27 | 2016-08-04 | La Vita Compounding Pharmacy | Stable 5-methyltrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms |
US10406159B2 (en) | 2015-01-27 | 2019-09-10 | La Vita Compounding Pharmacy | Stable 5-methyltetrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms |
US10849905B2 (en) | 2015-01-27 | 2020-12-01 | La Vita Compounding Pharmacy | Stable 5-methyltetrahydrofolate formulations to moderate methylenetetrahydrofolate reductase associated polymorphisms |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018001089A1 (en) | Valbenazine salts and polymorphs thereof. | |
BR112013017779A2 (en) | oxazine derivatives and their use in the treatment of neurological disorders | |
ECSP12011622A (en) | OXAZINE DERIVATIVES AND ITS USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
BR112013032974A2 (en) | "1,6-diazabicyclo [3,2,1] -octan-7-one derivatives, their uses, and pharmaceutical compositions". | |
BRPI0608840B8 (en) | pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea, and its preparation process | |
BR112012015916A2 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
BR112015014458A8 (en) | mannose derivatives, their intermediates, composition, use and preparation processes | |
BR112014011162A2 (en) | purine derivatives for the treatment of viral infections | |
UY33241A (en) | ? Tienopyrimidines containing heterocycloalkyl for pharmaceutical compositions ?. | |
BR112015020772A2 (en) | pyrimidine and pyridine compounds and their use | |
BR112012012529A2 (en) | indole compound and its pharmaceutical use | |
BR112013006344A2 (en) | piperdinyl substituted lactams as gpr119 modulators, pharmaceutical composition comprising them, use and process for preparing same | |
BR112013007457A8 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR OBTAINING THEM AND METHOD OF TREATMENT OF INTESTINAL DISEASE | |
BRPI0806400A8 (en) | compound, pharmaceutical composition, products, uses of at least one compound, in vitro method, kit, binders and process for preparing a compound | |
UY34239A (en) | FENIL-3-AZA-BICICLO [3,1,0] HEX-3-IL-METANONAS AND ITS USE AS A MEDICINAL PRODUCT | |
BR112014018767A8 (en) | FUSED PYRROLDICARBOXAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITION INCLUDING THEM | |
BR112014001908A2 (en) | substituted heterocyclic aza derivatives | |
ECSP11010956A (en) | COMPOUNDS LINKED WITH SULFUR FOR THE TREATMENT OF DISEASES AND OPHTHALMIC DISORDERS | |
BR112019011462A2 (en) | gip / glp-1 coagonist peptide; and, peptide for use in the treatment and / or prophylaxis of clinical alzheimer's disease. | |
AR084832A1 (en) | OXAZINE CRYSTAL DERIVATIVE | |
DOP2013000314A (en) | TYPICAL OPHTHALMOLOGICAL PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB | |
BR112015030774A2 (en) | new compounds for cancer treatment | |
BR112015030678A8 (en) | 4-amino-6-phenyl-5,6-dihydroimidazo [1,5-a] pyrazine derivatives as beta-secretase (bace) inhibitors, pharmaceutical composition, process for preparing the same, and uses in the manufacture of medicines | |
GT200700097A (en) | NEW DERIVATIVES OF PHENYLPIRIDINYLPIPERAZINE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
BRPI1011851A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR INDUCING APOPTOSIS IN A CELL, AND TO TREAT A DISEASE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06V | Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Decision: refusal | ||
B12B | Appeal: appeal against refusal |